Der Kaninchen-Polyklonal Anti-MAPK14-Antikörper wurde für WB und IHC validiert. Er ist geeignet zum Nachweis von MAPK14 in Proben aus Human, Maus, Ratte, Hund, Rind (Kuh) und Xenopus laevis.
}
WB: 0.2-1 µg/mL Optimal conditions should be determined by the investigator.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Konzentration
Lot specific
Buffer
Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
4 °C/-20 °C
Informationen zur Lagerung
Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
Target
MAPK14
(Mitogen-Activated Protein Kinase 14 (MAPK14))
Andere Bezeichnung
MAPK14
Hintergrund
MAPK14 encodes a protein which is a member of the MAP kinase family. MAP kinases act as an integration point for multiple biochemical signals, and are involved in a wide variety of cellular processes such as proliferation, differentiation, transcription regulation and development. This kinase is activated by various environmental stresses and proinflammatory cytokines. The activation requires its phosphorylation by MAP kinase kinases (MKKs), or its autophosphorylation triggered by the interaction of MAP3K7IP1/TAB1 protein with this kinase. The substrates of this kinase include transcription regulator ATF2, MEF2C, and MAX, cell cycle regulator CDC25B, and tumor suppressor p53, which suggest the roles of this kinase in stress related transcription and cell cycle regulation, as well as in genotoxic stress response. Synonyms: Polyclonal MAPK14 antibody, Anti-MAPK14 antibody, mitogen-activated protein kinase 14 antibody.